Bcl2 is a known anti-apoptotic protein that is frequently examined for potential clinical use as a prognostic biomarker in cancer, and its overexpression is associated with resistance to cytotoxic drugs such as cisplatin and 5-fluorouracil. This evidence concerns the gene BCL2 and cancer.